Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content
Conoravirus Disease Portal

Coronavirus Disease PHGKB|Home|PHGKB Last data update: Apr 07, 2020 . (Total: 7116 Documents since 2000)
       COVID-19 only

Last Posted: Apr-07-2020 10:27:45
spot light Spotlight on COVID-19

Rapid implementation of mobile technology for real-time epidemiology of COVID-19
DA Drew et al, MEDRXIV, April 6, 2020

The COronavirus Pandemic Epidemiology (COPE) consortium brings together scientists with expertise in big data research and epidemiology to develop a COVID-19 Symptom Tracker mobile application garnering more than 2.25 million users to date. This mobile application offers data on risk factors, herald symptoms, clinical outcomes, and geographical hot spots.

COVID-19 PM2.5: A national study on long-term exposure to air pollution and COVID-19 mortality in the United States
Harvard University, April 6, 2020

Data was collected for approximately 3,000 counties in the United States (98% of the population) up to April 04, 2020. The study found that an increase of only 1 µg/m3 in PM2.5 is associated with a 15% increase in the COVID-19 death rate, 95% confidence interval (CI) (5%, 25%). Results are statistically significant and robust to secondary and sensitivity analyses.

Coronavirus Disease 2019 and Children: What Pediatric Health Care Clinicians Need to Know
SA Rasmussen et al, JAMA Pediatrics, April 5, 2020

While early data suggest that #COVID19 effects on children are less severe than those on adults, yet many questions remain, especially regarding the effects on children with special health care needs.

Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020
CDC MMWR, April 6, 2020

Among 345 pediatric cases, 80 (23%) had at least one underlying condition. The most common underlying conditions were chronic lung disease (including asthma) (40), cardiovascular disease (25), and immunosuppression (10). 77% of hospitalized patients, including all six patients admitted to an ICU, had one or more underlying medical condition.

news Latest News and Publications
A global needs assessment in times of a global crisis: world psychiatry response to the COVID-19 pandemic.
Kaufman Kenneth R, et al. BJPsych open 2020 4 0. 1-11


Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy.
Jensen Jeffrey D, et al. Heredity 2020 4 0.


Structural Variations in Human ACE2 may Influence its Binding with SARS-CoV-2 Spike Protein.
Hussain Mushtaq, et al. Journal of medical virology 2020 4 0.


About the origin of the first two Sars-CoV-2 infections in Italy: inference not supported by appropriate sequence analysis.
Carletti Fabrizio, et al. Journal of medical virology 2020 4 0.


One proline deletion in the fusion peptide of neurotropic mouse hepatitis virus (MHV) restricts retrograde axonal transport and neurodegeneration.
Rout Saurav Saswat, et al. The Journal of biological chemistry 2020 4 0.

Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
Kim Eun, et al. EBioMedicine 2020 4 0. 102743


Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic.
Tuech J-J, et al. Journal of visceral surgery 2020 3 0.


A potential protective role of losartan against coronavirus-induced lung damage.
Zeinalian Mehrdad, et al. Infection control and hospital epidemiology 2020 3 0. 1-2

Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads.
Pan Yang et al. Clinical chemistry 2020 Apr


The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges.
Tang Yi-Wei et al. Journal of clinical microbiology 2020 Apr



Sign up Email Alert

About Coronavirus Disease Portal

Coronavirus Disease Portal is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that captures emerging discoveries and applications of genomics, molecular and other precision medicine and precision public health tools in the investigation and control of coronaviruses, such as COVID-19, MERS-CoV, and SARS. Contents of Coronavirus Disease Portal include PubMed records via an automated pubmed search algorithm, the relevant information picked by experts, and linkages to contents from our curated PHGKB databases.

Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.